← All Dossiers
Indigo – Growth Round
Long-Term Cultivation StoryHouse Fund II  ·  Growth Round  ·  Healthcare and Life Sciences  ·  Bay Area, CA
Dossier generated 2026-07-10 by /deal-dossier  ·  Deal record: recKllUhAfgwT36wT  ·  Source: Airtable appjxAR3LPe3fkHOp

One-Liner & Thesis

Indigo helps physicians achieve independence — starting, operating, and growing their own practices — by owning the legal and operational workflows most incumbents ignore, and it has reportedly reached ~$9M ARR in 16 months since Fika's seed. The wedge (practice formation, credentialing, compliance, ops) sits directly on a real reversal: physician-owned practices have fallen sharply, but autonomy pressure and 2025 anti-PE-rollup laws are pushing doctors back toward ownership (Internal/Web).

The founder is exceptional: Joshua Gordon (Pitzer '05, UCLA MD, practicing orthopedic hand surgeon, Wharton MBA '21), with a Wharton co-founder and operators who have scaled companies from $500K to $60M+ ARR. He is deliberately stealth and not actively raising; the next round would likely be growth equity, past StoryHouse's core stage. The realistic path is a small relationship check (~$1M, possibly uncapped) if leads leave room — an optionality-and-relationship position, not a fund-returner. Josh has also floated becoming a StoryHouse LP.

The independent-practice market is at an inflection: non-physician ownership hit ~64% of practices in 2025, but physician autonomy concerns, an ~11% self-employed pay premium, and 2025 anti-PE-rollup laws in 7 states are pushing doctors back toward ownership (Web). Practice-management software is a ~$17B market compounding ~10% annually inside a ~$129B physician-practice-management category (Web). A platform that removes the legal, credentialing (90-180 days/payer), and operational friction of starting a practice targets a real, growing pain point, and enablement/MSO consolidators (Privia, Aledade) provide a demonstrated exit market (Web).

Investment Score & Recommendation

71/ 100
INVEST

Elite founder-market fit and reportedly ~$9M ARR in 16 months (Internal) drive a strong score; the drag is deal structure: a late-stage minority check (~$1M) into an uncapped, high valuation with no guaranteed allocation and access actively restricted by the founders.

Momentum: AcceleratingRed flags: 3 / 9Confidence: Low
Market & TAM8/10
25% weight
Team & Founder9/10
25% weight
Product & Traction8/10
20% weight
Deal Terms3/10
20% weight
VC Syndicate6/10
10% weight

Deal Box

Funding Round
Growth Round
Lead Investor
Fika Ventures (seed)
Reported ARR
~$9M (16 mo post-seed)
Fund
StoryHouse Fund II
Status
Not actively raising

Company Snapshot

Sector
Healthcare · Legal · Platform
Location
Bay Area, CA
Year Founded
2025 (operating ~3 yrs)
Website
https://www.getindigo.io/physicians
Status
Private (stealth)

Market Size

$17B
Practice Mgmt Systems TAMWeb
2025 → ~$44B by 2035
~10%
Market CAGRWeb
PMS software, '25-'35
$129B
Broader Physician Practice MgmtWeb
2024, ~8.5% CAGR to $292B by 2034

Large, structurally growing market with a genuine independent-practice tailwind: only ~36% of practices remain physician-owned (down sharply since 2018), but many physicians want physician-owned settings and 7 states passed 2025 laws curbing PE roll-ups (Web). Indigo's legal/ops wedge for starting and running an independent practice sits directly on that reversal.

Competition

PlayerPositioningFunding / StageEdge vs. them
Indigo (getindigo.io)Legal + operational workflow platform to help physicians start, run, and grow independent practicesFika-led seed
TebraIntegrated EHR + practice-management SaaS for small/independent practicesKareo+PatientPop merger, PE-backedIncumbent breadth, large installed base
AledadeVBC/ACO enablement for independent primary care$260M Series F (unicorn)Payer contracts + VBC economics at scale
Privia HealthPublic physician enablement / MSO platformPublic (~$2.7B mkt cap)National medical group, VBC infrastructure
CardioOne / Pearl / LumerisSpecialty & primary-care enablement / MSO platformsVC + PESpecialty depth, VBC tooling

Moat: Wedge is the underserved legal/compliance/formation layer (PLLC setup, credentialing, ops) rather than EHR or VBC contracting, letting Indigo own the practice-formation moment most incumbents ignore.

Traction

~$9M
ARRInternal
16 mo post-seed (per Fika)
~3 yr
Operating HistoryInternal
$500K→$60M+
Team's Prior ARR ScalingInternal

Exit Potential

Strategic M&A / IPO
Likely Path
4-7 yr
Time to Liquidity
~1.5-3x
Return ScenarioInternal

Natural acquirers are physician-enablement / PMS consolidators and PE MSOs: Privia (~$2.7B cap), Tebra, agilon, Aledade, or health-system/insurer buyers; specialty enablement M&A is active (Privia bought Evolent Care Partners; CardioOne acquired by WindRose) (Web). Public healthcare-services multiples compressed to ~11.5x EV/EBITDA in 2025, with platform deals still double-digit. Return math is the constraint: a ~$1M minority check at an uncapped/high growth-stage valuation caps the outcome at ~1.5-3x even on a strong exit, making this a relationship/optionality position rather than a fund-returner (Internal).

Founders

Joshua Gordon
Co-Founder
Pitzer '05 (Chemistry), UCLA MD, UPenn orthopedic surgery residency, Wharton MBA '21; a practicing orthopedic hand & microsurgeon, which is operationally relevant to Indigo. Deeply mission-driven and Claremont-affiliated; started the company ~3 years ago with a Wharton classmate.
Elva Fu
Founding Team
CMC grad and early team member; StoryHouse has connected with her several times, though she kept the company deliberately quiet.

Open Questions & Risks

Next Steps

Latest Meeting Notes

2026-07-03 First founder call Finally on the phone with Josh Gordon

A long (90-minute) first call after a long chase. Sharp, thoughtful, very cagey on specifics; strong Claremont affinity; open to a relationship but no commitment.

Source: Meeting Notes recLWi4b699rt2FXn
2026-05-04 Intel Fika flags a Claremont founder

Julia Puzzo (Fika) surfaced Indigo while planning the SF event: ~$9M ARR in 16 months, with a Pitzer co-founder (Josh Gordon) StoryHouse hadn't realized was a founder.

Source: Meeting Notes recH2L2MoMijOqvgz

Deal Timeline